No Data
No Data
Atara Biotherapeutics, Inc.'s (NASDAQ:ATRA) High Institutional Ownership Speaks for Itself as Stock Continues to Impress, up 27% Over Last Week
Atara Biotherapeutics, Inc.'s (NASDAQ:ATRA) Price Is Right But Growth Is Lacking After Shares Rocket 32%
Atara Biotherapeutics (ATRA) Upgraded to Buy: Here's Why
Catalyst Watch: Eyes on Electric Vehicle Deliveries, Retail Data and Housing Reads
Atara Biotherapeutics Analyst Ratings
Rodman & Renshaw Initiates Coverage on Atara Biotherapeutics With Buy Rating, $25 Price Target
Unlock the Full List